Maria Pagoni

Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial

Andrew H. Wei, Pau Montesinos, Vladimir Ivanov et al. · Blood · 2020 · 756 citations · Full text

Medicine, Oncology, Pharmacology +9

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Johan Richter, Joëlle Guilhot, Franz Gruber et al. · The Lancet Oncology · 2018 · 611 citations · Full text

Medicine, Oncology, Pharmacology +11

Blockchain-based food supply chain traceability: a case study in the dairy sector

Fran Casino, Venetis Kanakaris, Thomas K. Dasaklis et al. · International Journal of Production Research · 2020 · 398 citations

Management, Dairy Science, Supply Chain Management +17

A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies

Maria N. Gamaletsou, Thomas J. Walsh, Theoklis E. Zaoutis et al. · Clinical Microbiology and Infection · 2013 · 110 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +10

Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: Results from the Hellenic Dendritic Cell Leukemia Study Group

Nikolaos J. Tsagarakis, Nektaria Kentrou, Konstantinos A. Papadimitriou et al. · Leukemia Research · 2009 · 104 citations

Life Sciences, Hematology, Immunology +7